ALSTHOM-ATLANTIQUE – Trademark Portfolio
Entity Type: 03
ALSTHOM-ATLANTIQUE has 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include NEYRFOR. The portfolio includes 1 registered trademark. Filings span 6 Nice Classification classes, led by Class 7 (Machinery) and Class 9 (Computers & Electronics). This trademark owner is based in 75016 PARIS.
38, AVENUE KLEBER
75016 PARIS , FR
Showing of trademarks Trademarks
Trademark Classifications
ALSTHOM-ATLANTIQUE's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Machines and machine tools; motors and engines; machine coupling and transmission components
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Frequently Asked Questions
How many trademarks does ALSTHOM-ATLANTIQUE have?
ALSTHOM-ATLANTIQUE has 14 U.S. trademarks filed with the USPTO. Of these, 1 registered, 13 cancelled.
What trademark classes does ALSTHOM-ATLANTIQUE file in?
ALSTHOM-ATLANTIQUE files trademarks across 6 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 9 (Computers & Electronics), Class 11 (Environmental Control), Class 1 (Chemicals), Class 8 (Hand Tools). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.
What are ALSTHOM-ATLANTIQUE's most well-known trademarks?
ALSTHOM-ATLANTIQUE's registered trademark portfolio includes well-known marks such as NEYRFOR. These are among 1 currently registered trademark in the portfolio.
What is ALSTHOM-ATLANTIQUE's trademark registration success rate?
ALSTHOM-ATLANTIQUE has a 7% trademark registration rate, with 1 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.